Cargando…

Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease

Sleep disturbances are common in patients with Parkinson's disease (PD) and are even more prevalent in patients with behavioural addictions, such as pathological gambling, compulsive sexual behaviour, compulsive buying, binge eating, punding, and the compulsive use of dopamine replacement thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Djamshidian, Atbin, Poewe, Werner, Högl, Birgit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667074/ https://www.ncbi.nlm.nih.gov/pubmed/26664825 http://dx.doi.org/10.1155/2015/970862

Ejemplares similares

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Reflection impulsivity perceptual decision‐making in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2018)

Birds of a Feather Flock Together: Disadvantageous Decision Making in Augmented Restless Legs Syndrome Patients with and without Impulse Control Disorders
por: Heim, Beatrice, et al.
Publicado: (2021)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study
por: Marini, Kathrin, et al.
Publicado: (2021)

Haste makes waste: Decision making in patients with restless legs syndrome with and without augmentation
por: Heim, Beatrice, et al.
Publicado: (2017)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease
por: Mahlknecht, Philipp, et al.
Publicado: (2016)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: a retrospective analysis
por: Barbosa, Pedro, et al.
Publicado: (2021)

Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations
por: Carbunaru, Samuel, et al.
Publicado: (2018)

Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study
por: Poewe, Werner, et al.
Publicado: (2021)

Effects of Dopamine on Sensitivity to Social Bias in Parkinson's Disease
por: Djamshidian, Atbin, et al.
Publicado: (2012)

Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
por: Stockner, Heike, et al.
Publicado: (2012)

Augmentation in restless legs syndrome: an eye tracking study on emotion processing
por: Ellmerer, Philipp, et al.
Publicado: (2020)

Parkinson's Disease and Sleep/Wake Disturbances
por: Swick, Todd J.
Publicado: (2012)

Factors associated with augmentation in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2021)

Impulse control disorders in Parkinson's disease
por: Stacy, Mark
Publicado: (2009)

Impulse control disorders in Parkinson’s disease
por: Bhattacharjee, Shakya
Publicado: (2020)

Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort
por: Marini, Kathrin, et al.
Publicado: (2020)

Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
por: Heim, Beatrice, et al.
Publicado: (2023)

α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023)

Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease
por: Rodríguez-Violante, Mayela, et al.
Publicado: (2019)

The Pathophysiology of Impulse control Disorders in Parkinson Disease
por: Balarajah, Sharmili, et al.
Publicado: (2013)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

Nightmare Disorder and Isolated Sleep Paralysis
por: Stefani, Ambra, et al.
Publicado: (2020)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Sleep-Wake Disorders
por: Gibb, William R G
Publicado: (1994)

Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
por: Roussakis, Andreas–Antonios, et al.
Publicado: (2019)

Genetic prediction of impulse control disorders in Parkinson's disease
por: Weintraub, Daniel, et al.
Publicado: (2022)

Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease
por: Martini, Alice, et al.
Publicado: (2019)

Differentiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis
por: Heim, Beatrice, et al.
Publicado: (2022)

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?
por: Houeto, Jean-Luc, et al.
Publicado: (2016)

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2016)

Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
por: Djamshidian, Atbin, et al.
Publicado: (2011)

REM sleep behavior disorder (RBD): Update on diagnosis and treatment
por: Högl, Birgit, et al.
Publicado: (2016)

Dopamine and reward hypersensitivity in Parkinson’s disease with impulse control disorder
por: Drew, Daniel S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h08umka6br3catjeph09p8jgog